Clinical investigation of human plasma-derived von Willebrand factor products - Scientific guideline

HumanScientific guidelines

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

This document summarises the clinical trials required for authorisation of new and modified human plasma derived von Willebrand factor products.

Keywords: Von Willebrand factor, von Willebrand disease

Current effective version

Guideline on the clinical investigation of human plasma derived Von Willebrand factor products (CPMP/BPWG/220/02)

Adopted Reference Number: CPMP/BPWG/220/02 Legal effective date: 01/06/2006

English (EN) (141.55 KB - PDF)

First published: 17/11/2005 Last updated: 17/11/2005